Submission Details
| 510(k) Number | K222852 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 21, 2022 |
| Decision Date | May 25, 2023 |
| Days to Decision | 246 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K222852 is an FDA 510(k) clearance for the Nipro SafeTouch Needle; Nipro Syringe with SafeTouch Needle, a Needle, Hypodermic, Single Lumen (Class II — Special Controls, product code FMI), submitted by Nipro Medical Corporation (Doral, US). The FDA issued a Cleared decision on May 25, 2023, 246 days after receiving the submission on September 21, 2022. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5570.
| 510(k) Number | K222852 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 21, 2022 |
| Decision Date | May 25, 2023 |
| Days to Decision | 246 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | FMI — Needle, Hypodermic, Single Lumen |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5570 |